Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
University of Pennsylvania
Cellectar Biosciences, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Hospices Civils de Lyon
AHS Cancer Control Alberta
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Institut Curie
Weill Medical College of Cornell University
Oslo University Hospital
Institute of Hematology & Blood Diseases Hospital, China
AbbVie
Washington University School of Medicine
Icahn School of Medicine at Mount Sinai
University of Arkansas
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Arbeitsgemeinschaft medikamentoese Tumortherapie
Second Affiliated Hospital, School of Medicine, Zhejiang University
University of Rochester
University of Rochester
US Oncology Research
Peter MacCallum Cancer Centre, Australia
Insel Gruppe AG, University Hospital Bern
M.D. Anderson Cancer Center
Peking Union Medical College Hospital
Amsterdam UMC, location VUmc
National Cancer Institute (NCI)
University of Leeds
International Myeloma Foundation
Weill Medical College of Cornell University
University of Nebraska
European Society for Blood and Marrow Transplantation
Canadian Cancer Trials Group
Singapore General Hospital
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Sun Yat-sen University
Eastern Cooperative Oncology Group
Imperial College Healthcare NHS Trust
Insel Gruppe AG, University Hospital Bern
University Hospital, Clermont-Ferrand
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
Hackensack Meridian Health